T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia

137Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In aplastic anemia, immune destruction of hematopoietic cells results in bone marrow failure. Type 1 cytokines, especially IFN-γ, have been implicated in the pathophysiology of T-cell-mediated, Fas-mediated stem cell apoptosis of hematopoietic cells. Here, we show that the transcription factor T-bet (T-box expressed in T cells) is increased in T cells from patients with aplastic anemia. Patients' T-bet bound directly to the proximal site of the IFN-γ promoter without any prior stimulation, in contrast to healthy controls. Increased levels of Itk kinase participated in T-bet up-regulation and active transcription of the IFN-γ gene observed in these patients. Blocking PKC-θ, a kinase that lies downstream of Itk kinase, decreased T-bet protein and IFN-γ intracellular levels. These data suggest that the increased IFN-γ levels observed in aplastic anemia patients are the result of active transcription of the IFN-γ gene by T-bet. Blocking the transcription of the IFN-γ gene with kinase inhibitors might lead to the development of novel therapeutic agents for patients with aplastic anemia and other autoimmune diseases. © 2006 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Solomou, E. E., Keyvanfar, K., & Young, N. S. (2006). T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood, 107(10), 3983–3991. https://doi.org/10.1182/blood-2005-10-4201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free